CHMP2B and nasopharyngeal carcinoma: Having validated our experimental approach, we next performed immunostaining and confocal imaging to evaluate the role of CHMP2B in CHMP7 mediated NPC injury, namely the reduction of nuclear POM121 immunoreactivity.